Tangeretin suppresses RANKL-induced osteoclastogenesis and alleviates postmenopausal osteoporosis by inhibiting Notch signaling

Background: Postmenopausal osteoporosis is characterized by osteoclast differentiation and bone loss. Tangeretin (TGN) is a natural product that possesses multiple pharmacological properties. However, its specific function in postmenopausal osteoporosis deserves further exploration. Methods: The in...

ver descrição completa

Detalhes bibliográficos

Principais autores:	Tengfei Wu, Fang Wang, Changqing Ai, Li Li, Fan Wu
Formato:	Artigo
Idioma:	Inglês
Publicado em:	Elsevier 2025-12-01
coleção:	Regenerative Therapy
Assuntos:	Postmenopausal osteoporosis TGN Osteoclast differentiation Notch signaling
Acesso em linha:	http://www.sciencedirect.com/science/article/pii/S2352320425000951
Tags:	Adicionar Tag Sem tags, seja o primeiro a adicionar uma tag!